Page last updated: 2024-12-08
pentaerythritol mononitrate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
pentaerythritol mononitrate: ester of pentaerythritol [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 150933 |
CHEMBL ID | 249808 |
SCHEMBL ID | 2293171 |
MeSH ID | M0107540 |
Synonyms (12)
Synonym |
---|
pentaerythritol mononitrate |
pentaerythrityl mononitrate |
CHEMBL249808 |
[3-hydroxy-2,2-bis(hydroxymethyl)propyl] nitrate |
unii-959217q3i8 |
959217q3i8 , |
1,3-propanediol, 2,2-bis(hydroxymethyl)-, 1-nitrate |
1607-00-7 |
1,3-propanediol,2,2-bis(hydroxymethyl)-, 1-nitrate |
SCHEMBL2293171 |
DTXSID20166970 |
Q27271767 |
Research Excerpts
Compound-Compound Interactions
Excerpt | Reference | Relevance |
---|---|---|
" A study undertaken in dogs has also been made of the pharmacokinetics of the major nitrated metabolite of PETN when the parent drug is administered with and without meprobamate and diphenhydramine." | ( A study of the plasma levels of pentaerythritol mononitrate following administration of pentaerythritol tetranitrate in combination with meprobamate and diphenhydramine. Aylott, RI; Draffan, GH; Gilbert, JD; Sögtrop, HH, 1982) | 0.55 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID352262 | Vasorelaxant activity in pig pulmonary artery by organ bath experiment | 2009 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 19, Issue:11 | NO donors. Part 18: Bioactive metabolites of GTN and PETN--synthesis and vasorelaxant properties. |
AID309710 | Vasodilatory effect in pig pulmonary artery assessed as inhibition of PGF2-alpha-induced contraction | 2007 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 17, Issue:21 | NO donors. Part 16: investigations on structure-activity relationships of organic mononitrates reveal 2-nitrooxyethylammoniumnitrate as a high potent vasodilator. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.74
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.74) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |